Intensive Studies for Recertification: Compounded Sterile Preparations Pharmacy (Cert # L239228)
ACPE Numbers: Various – see listing below
Content Release Date: 08/23/2023
Expiration Date: 08/20/2024
Activity Type: Application-based
CE Credits: 6.0 contact hours (BPS and ACPE)
Activity Fee: $100 (ASHP member); $150 (non-member)
Activity Overview
The Intensive Study Package is intended for board certified pharmacists in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS). Using a case-based approach, the activities provide high-level, interactive discussions on contemporary and emerging issues in compounding sterile preparations.
These activities are part of the ASHP professional development program for BCSCP recertification approved by BPS.
These activities were part of the 2022 ASHP Midyear Clinical Meeting and Exhibition and 2023 ASHP Summer Meetings and Exhibition. Learners who previously claimed ACPE credit for these activities should not claim ACPE credit again.
Accreditation
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
Target Audience
These recertification activities are intended for board certified pharmacists seeking to update their knowledge and skills in:
- Parenteral Nutrition Continuum
- Monthly Surface Sampling
- Cleanroom Excursions
Recertification Credit
Board certified pharmacists are eligible to receive up to 6.0 contact hours of recertification credit for completing this package. To earn recertification credit, learners must review the activity content and successfully complete the online assessments by the deadline. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.
Learning Activity |
ACPE Number |
Contact Hours |
Challenges Across the Parenteral Nutrition Continuum: Transcription, Compounding, Dispensing, Administration |
0204-0000-22-259-H07-P |
1.50 |
Challenges Across the Parenteral Nutrition Continuum: Clinical Assessment, Intervention, and Monitoring |
0204-0000-22-249-H01-P |
1.50 |
|
3.0 BPS |
|
Monthly Surface Sampling in the Cleanroom: Developing a Viable Plan |
0204-0000-23-136-H07-P |
1.00 |
Cleanroom Excursions: Don't Let Issues Compound |
0204-0000-23-965-H07-P |
2.00 |
|
3.0 BPS |
Learning Objectives
Challenges Across the Parenteral Nutrition Continuum: Transcription, Compounding, Dispensing, Administration
ACPE #: 0204-0000-22-259-H07-P
Learning Objectives
At the conclusion of this application-based educational activity, participants should be able to do the following:
- Evaluate best practices for minimizing work arounds in parenteral nutrition transcription processes.
- Solve common clinical challenges faced while compounding parenteral nutrition.
- Analyze challenges that arise when dispensing parenteral nutrition.
- Design a plan for the administration of parenteral nutrition that encompasses a variety of locations (e.g., inpatient, home infusion).
Challenges Across the Parenteral Nutrition Continuum: Clinical Assessment, Intervention, and Monitoring
ACPE #: 0204-0000-22-249-H01-P
Learning Objectives
At the conclusion of this application-based educational activity, participants should be able to do the following:
- Given a patient scenario, apply clinical factors that should be considered when assessing candidates for parenteral nutrition.
- Given a patient scenario, apply practical strategies to safely and effectively implement parenteral nutrition.
- Given a patient scenario, develop a parenteral nutrition monitoring plan to assess progress toward therapeutic goals and adjustments to therapy.
Monthly Surface Sampling in the Cleanroom: Developing a Viable Plan
ACPE #: 0204-0000-23-136-H07-P
Learning Objectives
At the conclusion of this application-based educational activity, participants should be able to do the following:
- Identify viable environmental and surface sampling requirements of the USP Chapter <797>.
- Given a scenario, evaluate whether appropriate procedures for surface sampling were used.
- Interpret data obtained from surface sampling.
Cleanroom Excursions: Don't Let Issues Compound
ACPE #: 0204-0000-23-965-H07-P
Learning Objectives
At the conclusion of this application-based educational activity, participants should be able to do the following:
- Outline the requirements and recommendations within USP <797> on actionable environmental monitoring limits of a cleanroom.
- Evaluate appropriate corrective and preventative actions of presented examples on cleanroom excursions.
- Design a comprehensive corrective action and preventive action (CAPA).
Faculty
Angela L. Bingham, PharmD, BCCCP, BCNSP, BCPS, FASHP, FASPEN, FCCP
Vice Chair and Associate Professor of Clinical Pharmacy
Philadelphia College of Pharmacy
Philadelphia, Pennsylvania
Rochelle J. Bussa, PharmD
IV Room Supervisor
Kings Daughters Medical Center
Ashland, Kentucky
Ashley Duty, PharmD, MS, BCSCP, FASHP*
Director of Inpatient Pharmacy Operations
Nationwide Children's Hospital
Westerville, Ohio
Kevin N. Hansen, PharmD, MS, BCPS, BCSCP*
Director of Pharmacy
Cone Health
Greensboro, North Carolina
Haley L. Kavelak, PharmD, BCCCP
Critical Care Clinical Pharmacy Specialist
St. Luke's University Health Network
Bethlehem, Pennsylvania
Kristen Kruszewski, PharmD, BCSCP
Assistant Director
Integrated Pharmacy Supply Chain Management
UNC Health
Durham, North Carolina
Patricia C. Kienle, BSPharm, MPA , BCSCP, FASHP*
Director, Accreditation and Medication Safety
Cardinal Health Innovative Delivery Solutions
Wilkes-Barre, Pennsylvania
Erinn Rowe, PharmD, MS
Clinical Manager
UNC Health
Chapel Hill, North Carolina
*Content matter experts
Reviewers
Angela T. Cassano, PharmD, BCPS, FASHP
Sue Dombrowski, MS, RPh
Ashley Duty, PharmD, MS, BCSCP
Kevin Hansen, PharmD, MS, BCPS, BCSCP
Patti Kienle, RPh, MPA, BCSCP, FASHP
Field Testers
Raymond Antypas, PharmD, MPH, BCSCP
Gina Bliss, PharmD, BCSCP
Isaac Buabeng, PharmD, BCPS, BCSCP
Ashlyn Carter, PharmD, BCSCP
Leroy Bryce Carter, PharmD, BCSCP
Stella Chaphiv, PharmD, BCSCP, MPH
Liatte Closs, PharmD, BCSCP
Scott Collins, PharmD, BCPS, BCSCP
Liubov Deyneko, PharmD
Dalavia Edmon, PharmD, BCSCP
Olubunmi Fiki-Afolabi, PharmD, BCSCP
Jeseli Flores, PharmD, MBA, BCPS, BCSCP
Jeanne Frenzel, PharmD, PhD, BCSCP
Joanne Glatz, PharmD, BCSCP
Tareq Haddad, RPh, MRPharmS, BCSCP
Miranda Healy, PharmD, BCPS, BCSCP
Melanie Horn, PharmD
Morgan Humphrey, PharmD, MBA, BCPS, BCSCP
Elizabeth Jimmerson, PharmD, BCSCP
Daisy Leong, PharmD, BCPS, BCSCP
Austin Mach, PharmD, BCSCP
Megan Martin, PharmD, BCSCP
Jessica Mazzone, PharmD
Elham Mohamed, BCSCP
Kim Nguyen, PharmD, BCSCP
Khang Pham, PharmD, BCSCP
Rosanna Ressing, PharmD, BCSCP
Jocelyn Reynoso, PharmD, BCPS, BCGP, BCSCP
Christopher Roy, PharmD BCSCP
Kyle Sabol, PharmD, BCPS, BCSCP
Monazzah Sarwar, PharmD, BCSCP
Elizabeth Schar, BSPharm, DPLA, BCSCP
Scott Shepard, PharmD, BCSCP
Darren Stevens, PharmD, MBA, BCSCP, DPLA
Wai Tak Sung, PharmD, BCOP, BCSCP
Christy Turner, BSPharm, MBA, BCSCP
Anna Usherenko, PharmD, BCSCP
Albert Villaluna, BS, BCSCP
Relevant Financial Relationship Disclosure
In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.
The following persons in control of this activity’s content have relevant financial relationships:
Kevin Hansen: Baxter Healthcare: Advisor, Speaker's bureau; Omnicell: Advisor, Speaker's bureau
All other persons in control of content do not have any relevant financial relationships with an ineligible company.
As required by the Standards of Integrity and Independence in Accredited Continuing Education, all relevant financial relationships have been mitigated prior to the CPE activity.
Methods and CE Requirements
Activities consist of educational materials, assessments, and activity evaluations. In order to receive continuing pharmacy education credit, learners must:
- Complete the attestation statement
- Review all content
- Complete and pass the assessments
- Complete the evaluations
Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity.
Development
These activities were developed by ASHP.